IPO registrations (S-1, F-1) · Registrants
ANGIODYNAMICS INC
- SEC CIK
- 1275187 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2004-03-05, last 2004-05-12; 1 initial registration, 3 amendments
- Outcome
- Final prospectus filed 2004-05-27
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus 3841
- Incorporated in
- DE
- Business address
- 14 PLAZA DRIVE, Latham, NY 12110
- EIN
- 11-3146460
- Ticker
- ANGO (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ANGIODYNAMICS INC on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2004-05-12)
- Final price
- $11.00 per share, below the range (424B4 filed 2004-05-27, an initial public offering)
- Shares sold
- 1,950,000
- Gross proceeds
- $21,450,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ANGO
- Lead underwriters
- RBC Capital Markets (1,267,500 shares); Adams Harkness (682,500 shares)
- Syndicate
- H Ill
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ANGIODYNAMICS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: ANGIODYNAMICS, INC. Fuzzy (name and state)
- Business registration: ANGIODYNAMICS, INC. Fuzzy (name and state)
- Business registration: ANGIODYNAMICS, INC. Fuzzy (name and state)
- Form 5500 plan sponsor: ANGIODYNAMICS, INC. EXACT (EIN (EXACT))
- Federal award recipient: ANGIODYNAMICS INC Fuzzy (name and state)
- Federal award recipient: ANGIODYNAMICS, INC. Fuzzy (name and state)
- Lobbying client: ANGIODYNAMICS INC Fuzzy (name and state)
- SEC filer: ANGIODYNAMICS INC EXACT (CIK (EXACT))
- Person page: D Joseph Gersuk Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
- Person page: Eamonn P Hobbs Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
- Person page: James C Clemmer Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer))
- Person page: Mark T Frost Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer))
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2004-03-05 | S-1 | S-1 (registration) | ANGIODYNAMICS INC | 0001193125-04-035562 ↗ |
| 2004-04-15 | S-1/A | S-1/A (amendment) | ANGIODYNAMICS INC | 0001193125-04-063233 ↗ |
| 2004-05-05 | S-1/A | S-1/A (amendment) | ANGIODYNAMICS INC | 0001193125-04-079404 ↗ |
| 2004-05-12 | S-1/A | S-1/A (amendment) | ANGIODYNAMICS INC | 0001193125-04-084986 ↗ |
| 2004-05-27 | 424B4 | 424B4 (final prospectus) | ANGIODYNAMICS INC | 0001193125-04-095081 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2004-05-12 | S-1/A | registration statement | $12.00–$14.00 | $13.00 | 1,950,000 | $25,350,000 | Nasdaq ANGO | 2 | primary document; range, price sentence, shares headline, proceeds computed, cover names 1 | document ↗ |
| 2004-05-27 | 424B4 | final prospectus | $11.00 | 1,950,000 | $21,450,000 | Nasdaq ANGO | 3 | primary document; price sentence, shares headline, proceeds table, underwriting table 2, cover names 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| APPLING WILLIAM M | Officer | Vice-President - Research | 12 | 2006–2010 | |
| GERARDI JOSEPH G | Officer | Vice President; Vice President - CFO | 12 | 2006–2007 | |
| HOBBS EAMONN P | Director,Officer | President & CEO | 31 | 2006–2009 | person page Fuzzy |
| MEYERS DAVID P | Director | 17 | 2006 | ||
| GRAHAM PETER J | Director | 4 | 2006 | ||
| Estate of Howard S. Stern | TenPercentOwner | 2 | 2006 | ||
| Stern Linda B | TenPercentOwner | 30 | 2006 | ||
| DONNELLY HOWARD W | Director | 35 | 2006–2026 | ||
| ECHENBERG PAUL S | Director; Other | 17 | 2006–2012 | ||
| ROSSELL ROBERT M | Officer | VP - Marketing | 8 | 2006–2009 | |
| Casciaro Gregory D | Director | 1 | 2006 | ||
| FLAHERTY ROBERT E | Director | 4 | 2006–2008 | ||
| GOLD JEFFREY | Director | 24 | 2006–2019 | ||
| KUNST BRIAN | Officer | VP - Regulatory Affairs | 3 | 2006–2007 | |
| MAPES HAROLD | Officer | VP - Operations | 10 | 2006–2010 | |
| Meteny Dennis S | Director | 32 | 2006–2023 | ||
| RECINELLA DANIEL | Officer | VP - Product Development | 4 | 2006–2007 | |
| Shea Paul J | Officer | VP - Sales | 2 | 2006–2007 | |
| Mitchell Robert D | Officer | Executive VP and COO | 6 | 2006–2007 | |
| BUCCI VINCENT | Director | 20 | 2007–2013 | ||
| JOHNSON WESLEY | Director | 36 | 2007–2026 | ||
| LaPorte Steve | Director | 27 | 2007–2018 | ||
| SOTO JOHN | Officer | EVP and CCO; SVP and CCO; SVP - Global Franchise Leader; VP - International Sales; VP - OUS Sales | 15 | 2007–2015 | |
| GERSUK D JOSEPH | Officer | EVP - CFO; SVP - CFO | 14 | 2007–2012 | person page Fuzzy |
| Orsatti Charles Thomas | Director | 7 | 2008–2011 | ||
| McDonald David | Officer | SVP - Business Development | 1 | 2009 | |
| Morris Sean | Officer | SVP - General Manager | 1 | 2009 | |
| Keltjens Jan | Director,Officer; Officer | President & CEO | 7 | 2009–2011 | |
| McCarthy Shawn P | Officer | SVP - General Manager | 4 | 2009–2010 | |
| McGill Stephen | Officer | SVP - General Manager; SVP, General Manager; SVP, GM - International | 13 | 2009–2014 | |
| Wallace Lynda M. | Officer | SVP - Business Development | 2 | 2010 | |
| Solano Scott J. | Officer | Interim CEO; Senior Vice Preisdent - CTO; Senior VP, CTO | 3 | 2010–2011 | |
| Etlinger Richard Scott | Officer | SRVPGLOP; SVP - Global Operations; SVP-Global Operations | 5 | 2010–2012 | |
| Gould Kevin J | Director | 18 | 2010–2020 | ||
| DEVIVO JOSEPH | Director,Officer; Officer | President and CEO; President and Chief Executive | 25 | 2011–2015 | |
| PANZER ALAN | Officer | SVP, GM - Vascular | 3 | 2011–2012 | |
| Kapusta Matthew C | Officer | SVP, Business Development | 13 | 2011–2014 | |
| Richard Stark | Officer | SVP, GM - Oncology | 24 | 2012–2017 | |
| Avista Capital Partners GP, LLC | TenPercentOwner | 4 | 2012–2017 | ||
| Avista Capital Partners, L.P. | TenPercentOwner | 4 | 2012–2017 | ||
| Avista Capital Partners (Offshore), L.P. | TenPercentOwner | 4 | 2012–2017 | ||
| Burgstahler David F | Director; Director,TenPercentOwner | 11 | 2012–2017 | ||
| Navilyst Medical Co-Invest, LLC | TenPercentOwner | 4 | 2012–2017 | ||
| Venkataraman Sriram | Director | 2 | 2012–2016 | ||
| Bourne George W. IV | Officer | CTO and COO; SVP and CTO; SVP and CT&OO | 10 | 2012–2014 | |
| Frost Mark T | Officer | EVP and CFO; Executive Vice President | 10 | 2012–2015 | person page Fuzzy |
| Greiner Charles R | Officer | VP - Global Finance; VP - Global Franchise | 15 | 2012–2016 | |
| Trowbridge Stephen A | Officer | EVP and CFO; EVP, General Counsel and CFO; SVP and General Counsel | 61 | 2014–2026 | |
| Clemmer James C | Director,Officer | President and CEO | 47 | 2016–2026 | person page Fuzzy |
| Greiner Michael | Officer | EVP and CFO | 12 | 2016–2019 | |
| Auen Eileen O'Shea | Director | 12 | 2016–2026 | ||
| REED JAN STERN | Director | 13 | 2016–2026 | ||
| Campbell Chad Thomas | Officer | SVP/GM, Vascular Access | 39 | 2017–2026 | |
| Simpson Robert Arthur | Officer | SVP/GM, Global Vascular | 9 | 2017–2019 | |
| Boucher Brent J. | Officer | SVP and GM of Oncology | 7 | 2019–2020 | |
| Helsel Dave | Officer | SVP Global Operations and R&D | 24 | 2019–2023 | |
| Licitra Karen A | Director | 9 | 2019–2026 | ||
| Centea Scott | Officer | Sr. VP/GM, Global VIT; SVP/GM, VIT | 13 | 2020–2023 | |
| Tarnoff Michael E | Director | 8 | 2020–2026 | ||
| ROSENZWEIG RICHARD C | Officer | SVP and General Counsel | 7 | 2021–2023 | |
| Piccinini Laura | Officer | SVP International | 16 | 2021–2026 | |
| Nighan Warren JR | Officer | SVP Quality and Regulatory | 15 | 2021–2026 | |
| Burgess Lorinda | Director | 5 | 2023–2026 | ||
| Weiss Lawrence T | Officer | SVP, Chief Legal Officer | 6 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Investment adviser | DIRECT ADVISORS, LLC | NY | Investment advisers (Form ADV) | same street address and ZIP code, 14 PLAZA DR 12110 (FUZZY: a shared address, not proof of a shared organization) |
| Business registration | ANGIODYNAMICS, INC. | NY | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | ANGIODYNAMICS, INC. | NY | State business registries | name and state |
| Business registration | ANGIODYNAMICS, INC. | NY | State business registries | name and state |
| Business registration | ANGIODYNAMICS, INC. | NY | State business registries | name and state |
| Federal award recipient | ANGIODYNAMICS INC | NY | Federal spending (USAspending) | name and state |
| Federal award recipient | ANGIODYNAMICS, INC. | NY | Federal spending (USAspending) | name and state |
| Lobbying client | ANGIODYNAMICS INC | NY | Federal lobbying (LDA) | name and state |
| Paying company | AngioDynamics, Inc. | NY | Open Payments (drug and device company payments) | name and state |
| Patent assignee | AngioDynamics, Inc. | NY | Patents (USPTO) | name and state |
| SEC filer | ANGIODYNAMICS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | AngioDynamics, Inc. | NY | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | ANGIODYNAMICS, INC. | EIN (EXACT) | ||
| Person page | D Joseph Gersuk | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) | |
| Person page | Eamonn P Hobbs | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer) | |
| Person page | James C Clemmer | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer) | |
| Person page | Mark T Frost | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Surgical & Medical Instruments & Apparatus, NY first:
- SWISSRAY INTERNATIONAL INC NY
- BIOPHAN TECHNOLOGIES INC NY
- DarioHealth Corp. NY
- iNeedMD Holdings, Inc. NY
- Nemaura Medical Inc. NY
- PAVmed Inc. NY
- Beyond Air, Inc. NY
- OMNIA WELLNESS INC. NY
- INTELLIGENT BIO SOLUTIONS INC. NY
- Lucid Diagnostics Inc. NY
In other datasets, the same topic (Technology) in NY:
- Lobbying client: 1ST ROCHDALE COOPERATIVE GROUP LTD (Federal lobbying (LDA))
Interests: Surgical & Medical Instruments & Apparatus · Technology